Fortune Mate Indonesia Tbk vs Champion Pacific Indonesia Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp252 (market cap 1.59T, 142.4K 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 4.1× Champion Pacific Indonesia Tbk.'s market cap, and Fortune Mate Indonesia Tbk is more actively traded (142.4K versus 16.2K). Which is the better fit depends on your goals.
| FMII | IGAR | |
|---|---|---|
Market Cap | 1.59T | 384.1B |
Volume | 142.4K | 16.2K |
Lot | 1.42K | 162 |
Turnover | 35.31M | 6.65M |
Average Price | 247.99 | 410.64 |
Value | 35.31M | 6.65M |
Indicative Equilibrium Price | 252 | 414 |
Indicative Equilibrium Volume | 33 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →